Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions, Volume 47 first published in 1977, presents clinicians and medical investigators with a critical survey of new data and trends in adverse drug reactions and interactions. Topics covered include ADRs, ADEs and SEDs: A Bird’s Eye View, Lithium, Drugs of abuse, Side effects of drugs used in the treatment of Alzheimer's disease, Sedatives and hypnotics, Antipsychotic agents, Anti-epileptic Medications, Side effects of opioid analgesics and narcotic antagonists, Anti-inflammatory and antipyretic analgesics and drugs used in gout, Side effects of local anesthetics and therapeutic gases, and more.
Other sections covered include Antihistamines (H1 receptor antagonists), Drugs that act on the respiratory tract, Positive inotropic drugs and drugs used in dysrhythmias, Beta adrenergic antagonists and antianginal drugs, Drugs acting on the cerebral and peripheral circulations, Antihypertensive drugs, and much much more.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Contributors - p. v 7. Preface - p. xvii 8. Special Reviews in SEDA 47 - p. xix 9. Table of Essays - p. xxi 10. Abbreviations - p. xxiii 11. ADRs, ADEs & Drug interactions in Medicine: What’s New? - p. xxvii 12. Chapter 1: Side effects of antidepressant use in pregnancy - p. 1 13. Chapter 2: Lithium-recent case studies on its side effects & adverse effects - p. 9 14. Chapter 3: Drugs of abuse - p. 15 15. Chapter 4: Current perspectives on the safety profile of Alzheimer’s disease pharmacotherapy - p. 33 16. Chapter 5: Sedative-hypnotics - p. 41 17. Chapter 6: Adverse effects of antipsychotic agents - p. 69 18. Chapter 7: Adverse effects associated with mu opioid receptor agonists, partial agonists, and antagonists - p. 79 19. Chapter 8: Anti-inflammatory and antipyretic analgesics and drugs used in gout - p. 91 20. Chapter 9: Neuromuscular blocking agents and skeletal muscle relaxants - p. 111 21. Chapter 10: Antihistamines (H1 receptor antagonists) - p. 115 22. Chapter 11: Side effects and adverse effects of drugs that act on the respiratory tract - p. 123 23. Chapter 12: Amiodarone, flecainide, and other antiarrhythmics used in dysrhythmia - p. 135 24. Chapter 13: Beta adrenergic antagonists and antianginal drugs - p. 147 25. Chapter 14: Side effects of antihypertensive agents: Calcium channel blockers, loop diuretics, alpha-2 agonists, beta-blockers, and vasodilators - p. 165 26. Chapter 15: Case studies on side effects of metals and metal antagonists - p. 179 27. Chapter 16: Side effects of antiseptic drugs and disinfectants - p. 189 28. Chapter 17: Side effects of tetracyclines and novel tetracycline derivatives - p. 201 29. Chapter 18: Side effects of antibiotics: Beta-lactams and tetracyclines - p. 209 30. Chapter 19: A review of recent clinical findings on adverse and toxic effects of antiprotozoal medications - p. 241 31. Chapter 20: Side effects of antifungals: Review of recent case studies - p. 249 32. Chapter 21: Adverse effects of clinically relevant antiviral drugs - p. 257 33. Chapter 22: Blood and blood treatments - p. 273 34. Chapter 23: Side effects of drugs that affect blood coagulation, fibrinolysis, and hemostasis - p. 281 35. Chapter 24: Recent clinical studies on the side effects of medications that influence corticotrophins, corticosteroids, and prostaglandins - p. 295 36. Chapter 25: Diuretics and associated adverse effects - p. 301 37. Chapter 26: Adverse reactions of drugs used in ocular treatment - p. 313 38. Chapter 27: Adverse drug reactions and adverse drug events associated with use of psychotropic, antihypertensive, antidiabetic, and antibiotic drugs in pregnancy - p. 323 39. Chapter 28: Side effects, ADRs and toxicity induced by diverse phytochemicals - p. 337 40. Chapter 29: Clinical case studies on resistance development to anticancer drugs: Challenges and therapeutic implications - p. 353 41. Chapter 30: Adverse effects associated with radiocontrast agents and radiopharmaceuticals - p. 361 42. Chapter 31: Central nervous system stimulants and drugs that suppress appetite - p. 373 43. Chapter 32: Toxicities and adverse reactions associated with lipid-lowering medications - p. 385 44. Chapter 33: Adverse effects and toxicity of anti-tuberculosis medications - p. 393 45. Chapter 34: ADRs and ADEs of drugs used metabolic bone disease - p. 409 46. Chapter 35: Nootropic agents - p. 419 47. Chapter 36: The evolving immunotherapy-associated toxicities in clinical medicine - p. 425 48. Chapter 37: Association of pharmacogenomics with ADRs, ADEs and toxicity of different classes of drugs - p. 457 49. Chapter 38: NAION (non-arteritic anterior ischemic optic neuropathy): Focus on semaglutide - p. 473 50. Reviewers - p. 483 51. Index of Drugs - p. 485 52. Index of Drug-Drug Interactions - p. 491 53. Index of Adverse Effects and Adverse Reactions - p. 493
Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions, Volume 47 first published in 1977, presents clinicians and medical investigators with a critical survey of new data and trends in adverse drug reactions and interactions. Topics covered include ADRs, ADEs and SEDs: A Bird’s Eye View, Lithium, Drugs of abuse, Side effects of drugs used in the treatment of Alzheimer's disease, Sedatives and hypnotics, Antipsychotic agents, Anti-epileptic Medications, Side effects of opioid analgesics and narcotic antagonists, Anti-inflammatory and antipyretic analgesics and drugs used in gout, Side effects of local anesthetics and therapeutic gases, and more.
Other sections covered include Antihistamines (H1 receptor antagonists), Drugs that act on the respiratory tract, Positive inotropic drugs and drugs used in dysrhythmias, Beta adrenergic antagonists and antianginal drugs, Drugs acting on the cerebral and peripheral circulations, Antihypertensive drugs, and much much more.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Contributors - p. v 7. Preface - p. xvii 8. Special Reviews in SEDA 47 - p. xix 9. Table of Essays - p. xxi 10. Abbreviations - p. xxiii 11. ADRs, ADEs & Drug interactions in Medicine: What’s New? - p. xxvii 12. Chapter 1: Side effects of antidepressant use in pregnancy - p. 1 13. Chapter 2: Lithium-recent case studies on its side effects & adverse effects - p. 9 14. Chapter 3: Drugs of abuse - p. 15 15. Chapter 4: Current perspectives on the safety profile of Alzheimer’s disease pharmacotherapy - p. 33 16. Chapter 5: Sedative-hypnotics - p. 41 17. Chapter 6: Adverse effects of antipsychotic agents - p. 69 18. Chapter 7: Adverse effects associated with mu opioid receptor agonists, partial agonists, and antagonists - p. 79 19. Chapter 8: Anti-inflammatory and antipyretic analgesics and drugs used in gout - p. 91 20. Chapter 9: Neuromuscular blocking agents and skeletal muscle relaxants - p. 111 21. Chapter 10: Antihistamines (H1 receptor antagonists) - p. 115 22. Chapter 11: Side effects and adverse effects of drugs that act on the respiratory tract - p. 123 23. Chapter 12: Amiodarone, flecainide, and other antiarrhythmics used in dysrhythmia - p. 135 24. Chapter 13: Beta adrenergic antagonists and antianginal drugs - p. 147 25. Chapter 14: Side effects of antihypertensive agents: Calcium channel blockers, loop diuretics, alpha-2 agonists, beta-blockers, and vasodilators - p. 165 26. Chapter 15: Case studies on side effects of metals and metal antagonists - p. 179 27. Chapter 16: Side effects of antiseptic drugs and disinfectants - p. 189 28. Chapter 17: Side effects of tetracyclines and novel tetracycline derivatives - p. 201 29. Chapter 18: Side effects of antibiotics: Beta-lactams and tetracyclines - p. 209 30. Chapter 19: A review of recent clinical findings on adverse and toxic effects of antiprotozoal medications - p. 241 31. Chapter 20: Side effects of antifungals: Review of recent case studies - p. 249 32. Chapter 21: Adverse effects of clinically relevant antiviral drugs - p. 257 33. Chapter 22: Blood and blood treatments - p. 273 34. Chapter 23: Side effects of drugs that affect blood coagulation, fibrinolysis, and hemostasis - p. 281 35. Chapter 24: Recent clinical studies on the side effects of medications that influence corticotrophins, corticosteroids, and prostaglandins - p. 295 36. Chapter 25: Diuretics and associated adverse effects - p. 301 37. Chapter 26: Adverse reactions of drugs used in ocular treatment - p. 313 38. Chapter 27: Adverse drug reactions and adverse drug events associated with use of psychotropic, antihypertensive, antidiabetic, and antibiotic drugs in pregnancy - p. 323 39. Chapter 28: Side effects, ADRs and toxicity induced by diverse phytochemicals - p. 337 40. Chapter 29: Clinical case studies on resistance development to anticancer drugs: Challenges and therapeutic implications - p. 353 41. Chapter 30: Adverse effects associated with radiocontrast agents and radiopharmaceuticals - p. 361 42. Chapter 31: Central nervous system stimulants and drugs that suppress appetite - p. 373 43. Chapter 32: Toxicities and adverse reactions associated with lipid-lowering medications - p. 385 44. Chapter 33: Adverse effects and toxicity of anti-tuberculosis medications - p. 393 45. Chapter 34: ADRs and ADEs of drugs used metabolic bone disease - p. 409 46. Chapter 35: Nootropic agents - p. 419 47. Chapter 36: The evolving immunotherapy-associated toxicities in clinical medicine - p. 425 48. Chapter 37: Association of pharmacogenomics with ADRs, ADEs and toxicity of different classes of drugs - p. 457 49. Chapter 38: NAION (non-arteritic anterior ischemic optic neuropathy): Focus on semaglutide - p. 473 50. Reviewers - p. 483 51. Index of Drugs - p. 485 52. Index of Drug-Drug Interactions - p. 491 53. Index of Adverse Effects and Adverse Reactions - p. 493
